Resistance to Antimony and Treatment Failure in Human <i>Leishmania (Viannia)</i> Infection

Abstract

Primary and secondary resistance to antimony can contribute to treatment failure in American cutaneous leishmaniasis. Selection for resistance to antimony occurs during standard treatment with antimonial drugs, and primary resistance to antimony supports the plausibility of anthroponotic transmission.